1. Monoclonal antibody to TNF in severe septic shock;Exley, A.R.; Cohen, J.; Buurman, W.; Owen, R.; Hanson, G.; Lumley, J.;Lancet,1990
2. Prevention ofGram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid;Baumgartner, J.-D.; Glauser, M.P.; McCutchan, J.A.; Zeigler, E.J.; van Melle, G.; Klauber, M.R.;Lancet,1985
3. Treatment of Gram-negative septic shock with an immunoglobulin preparation: a prospective CalraannddroamiTz;Schedel, I.; Dreikhausen, U.; Nentwig, B.; Hockenschnieder, M.; Rauthmann, D.; Balikcioglu, S.,1991
4. Immunization with rough mutants of salmonella minnesota: prospective activity of IgM and IgG antibody to the R595 (Re Chemotype) mutant;McCabe, W.R.; A, Jr, De Maria; Berberich, H.; Johns, M.A.;J Infect Dis,1988
5. Initial evvaluation of a human immunoglobuln M Fis1h9e90; C9:j17Z8-m84e. ra monoclonal antibody (HA-lA) in humans;Khazaeali, M.B.; Wheeler, R.; Rogers, K.; Ziegler, E.; Haynes, A.;CritCareMed; Initial evaluation of human monoclonal anti-lipid A antibody (HA-lA) in pautents with sepsis syndrome,1990